Parastomal Pyoderma Gangrenosum: A Case Report and Literature Review

Mancini, Gregory J.; Floyd, Lennis; Solla, Julio A.
September 2002
American Surgeon;Sep2002, Vol. 68 Issue 9, p824
Academic Journal
Parastomal pyoderma gangrenosum (PPG) is an exceedingly rare disease process most often observed in inflammatory bowel disease patients with an ileostomy. Fewer than 50 cases have been reported in the medical literature. The incidence is 0.6 per cent of patients with ileostomy and inflammatory bowel disease. The rarity of the disease leads to misdiagnosis and mistreatment of the lesion. The intense pain and disruption of ostomy function greatly impair affected individuals beyond the limit of their underlying disease. Current best care practices observed in small study series indicate long-term intensive medical therapy aimed at systemic disease suppression to optimize PPG wound healing. Our patient had no signs of active Crohn disease at the time of PPG presentation. She was initially treated with minimal wound debridement and intralesional triamcinolone. Finally under the care of an enterostomal/wound care therapist the patient achieved excellent PPG resolution in 6 months.


Related Articles

  • Probiotics and Immune Regulation of Inflammatory Bowel Diseases. Y. Cong; A. Konrad; N. Iqbal; C.O. Elson // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p145 

    Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the...

  • Inflammatory Bowel Disease.  // Current Medical Literature: Gastroenterology;2003, Vol. 22 Issue 2, p54 

    Presents citations and clinicians' notes about inflammatory bowel disease. 'High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease,' by J. Klaus, G. Armbrecht et al.; 'Primary chronic interstitial nephritis in Crohn's disease,' by H. Izzedine, J. Simon et al.

  • The treatment of inflammatory bowel disease in children. Wyllie, Robert; Sarigol, Samra // Clinical Pediatrics;Jul1998, Vol. 37 Issue 7, p421 

    Editorial. Discusses the treatment of inflammatory bowel disease in children. Symptoms of inflammatory bowel disease; Efficacy of metronidazole; Study on corticosteroid analogues; Nutritional intervention in Crohn's disease.

  • Inflammatory bowel disease. Galper, Charlotte; Cerda, James; Hanauer, Stephen B.; Peppercorn, Mark A.; Wexner, Steven D. // Patient Care;3/15/1998, Vol. 32 Issue 5, p81 

    Focuses on treatments for inflammatory bowel diseases (IBDs). Detailed information on ulcerative colitis (UC), crohn's disease (UC) and their treatments; Reference to nutritional therapy; Precautions with the use of corticosterioids for IBD patients; Indepth look at several therapies for IBD. ...

  • Prevalence of inflammatory bowel disease in British 26... Montgomery, S. M.; Morris, D. L.; Thompson, N.P.; Subhani, J.; Pounder, R.E.; Wakefield, A.J. // BMJ: British Medical Journal (International Edition);04/04/98, Vol. 316 Issue 7137, p1058 

    Presents information on a study investigating the prevalence of inflammatory disease in British 26 years olds. Characteristics of the subjects of the study; Methodology used in the study; Statistics on the result of the study.

  • Clarifications. Leidel, Jan // Deutsches Aerzteblatt International;12/9/2011, Vol. 108 Issue 49, p836 

    A letter to the editor is presented in response to the article "Vaccination Coverage in Immunosuppressed Patients--Results of a Regional Health Services Research Study," by Niels Teich and colleagues in the 2001 issue.

  • Technetium-99m autologous phagocyte scanning: a new imaging technique for inflammatory bowel disease. pullman, W.; Hanna, R.; Sullivan, P.; Booth, J.A.; Lomas, F.; Doe, William F. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p171 

    Examines the use of technetium (Tc)-99m autologous phagocyte scanning in determining the inflammatory bowel disease. Occurrence of terminal ileal Crohn's disease; Detection of mucosal inflammation; Advantages of Tc phaghocyte scan.

  • Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease. Prindiville, Thomas P.; Sheikh, Rafik A.; Cohen, Stuart H.; Tang, Yajarayma J.; Cantrell, Mary C.; Silva Jr., Joseph // Emerging Infectious Diseases;Mar/Apr2000, Vol. 6 Issue 2, p171 

    We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin...

  • Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. Williams, J. G.; Cheung, W. Y.; Lervy, B.; Russell, I. T.; Cohen, D. R.; Longo, M. // BMJ: British Medical Journal (International Edition);02/26/2000, Vol. 320 Issue 7234, p544 

    Provides information on a study which compared open access and routine booked appointments for follow-up of patients with inflammatory bowel disease. Participants and methods used; Results and discussion; Conclusion.

  • CORRECTION.  // CMAJ: Canadian Medical Association Journal;7/10/2012, Vol. 184 Issue 10, p1176 

    A correction to the article "Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort" that was published in the 2012 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics